Decitabine reactivated pathways in platinum resistant ovarian cancer

Combination therapy with decitabine, a DNMTi and carboplatin resensitized chemoresistant ovarian cancer (OC) to platinum inducing promising clinical activity. We investigated gene-expression profiles in tumor biopsies to identify decitabine-reactivated pathways associated with clinical response. Gen...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Fang, Fang, Zuo, Qingyao, Pilrose, Jay, Wang, Yinu, Shen, Changyu, Li, Meng, Wulfridge, Phillip, Matei, Daniela, Nephew, Kenneth P.
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2014
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116504/
https://ncbi.nlm.nih.gov/pubmed/25003579
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires